Tissue response to poly(l-lactic acid)-based blend with phospholipid polymer for biodegradable cardiovascular stents

Biomaterials

Volumn 32, Issue 9, 2011, Pages 2241-2247

  Kim, Hyung Il ^a,d,e   Ishihara, Kazuhiko ^a,e   Lee, Seungbok ^b   Seo, Ji Hun ^a,e   Kim, Hye Young ^c   Suh, Dongwhan ^b   Kim, Min Uk ^c   Konno, Tomohiro ^a,e   Takai, Madoka ^a   Seo, Jeong Sun ^b,d  

^a UNIVERSITY OF TOKYO   (Japan)

^b Seoul National University College of Medicine   (South Korea)

^c Seoul National University Hospital   (South Korea)

^d Macrogen Inc   (South Korea)

^e JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Cardiovascular stent; Phosphorylcholine group; Poly(lactic acid); Polymer blend; Tissue compatibility

Indexed keywords

AMPHIPHILICS; BIOABSORBABLE MATERIALS; BIOABSORPTION; CARDIOVASCULAR STENTS; CROSS SECTIONAL AREA; ENZYME LINKED IMMUNOSORBENT ASSAY; HIGH DENSITY; HIGH MOLECULAR WEIGHT; HUMAN PERIPHERAL BLOOD; IN-VITRO; IN-VIVO; INFLAMMATORY REACTION; INFRARENAL AORTA; INTERNAL CAROTID ARTERY; INTRAVASCULAR; NEGATIVE CONTROL; PHOSPHOLIPID POLYMERS; PHOSPHORYLCHOLINE; PLLA; POLY L LACTIC ACID; POLY(LACTIC ACID); PROINFLAMMATORY CYTOKINES; PROMISING MATERIALS; SUBCUTANEOUS TISSUES; THROMBUS FORMATION; TISSUE COMPATIBILITY; TISSUE RESPONSE;

BIOMATERIALS; BODY FLUIDS; HEMODYNAMICS; LACTIC ACID; ORGANIC POLYMERS; PHOSPHOLIPIDS; RATS; TISSUE; TUBING;

BIODEGRADABLE POLYMERS;

HEPARIN; PHOSPHOLIPID; PHOSPHORYLCHOLINE; POLYLACTIC ACID; POLYMER; WATER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; ARTICLE; BIODEGRADABILITY; BIOSORPTION; CARDIOVASCULAR EQUIPMENT; CAROTID ARTERY; CELL CULTURE; CONTROLLED STUDY; CORONARY STENT; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMPLANT; IMPLANTATION; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; INTERNAL CAROTID ARTERY; MALE; MOLECULAR WEIGHT; MONONUCLEAR CELL; MORPHOMETRICS; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RABBIT; RAT; RENAL ARTERY; STENT THROMBOSIS; SUBCUTANEOUS TISSUE; SURFACE PROPERTY; THROMBOGENESIS; THROMBUS; TISSUE REACTION;

ABSORBABLE IMPLANTS; ABSORPTION; ANIMALS; BIOCOMPATIBLE MATERIALS; CARDIOVASCULAR SYSTEM; CAROTID ARTERY, INTERNAL; CYTOKINES; HUMANS; IMPLANTS, EXPERIMENTAL; INFLAMMATION MEDIATORS; LACTIC ACID; LEUKOCYTES, MONONUCLEAR; MALE; METHACRYLATES; ORGAN SPECIFICITY; PHOSPHOLIPIDS; PHOSPHORYLCHOLINE; POLYMERS; PROSTHESIS IMPLANTATION; RABBITS; RATS; RATS, WISTAR; STENTS; SUBCUTANEOUS TISSUE; SURFACE PROPERTIES; THROMBOSIS;

ORYCTOLAGUS CUNICULUS; RATTUS;

EID: 78751702839     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2010.11.067     Document Type: Article

References (53)

1. Serruys P.W., Kutryk M.J., Ong A.T. Coronary-artery stents. N Engl J Med 2006, 354:483-495.
2. Mueller R.L., Sanborn T.A. The history of interventional cardiology: cardiac catheterization, angioplasty, and related interventions. Am Heart J 1995, 129:146-172.
3. Serruys P.W., Ormiston J.A., Onuma Y., Regar E., Gonzalo N., Garcia-Garcia H.M., et al. A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods. Lancet 2009, 373:897-910.
4. Ormiston J.A., Serruys P.W., Regar E., Dudek D., Thuesen L., Webster M.W., et al. A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial. Lancet 2008, 371:899-907.
5. Tamai H., Igaki K., Kyo E., Kosuga K., Kawashima A., Matsui S., et al. Initial and 6-month results of biodegradable poly-l-lactic acid coronary stents in humans. Circulation 2000, 102:399-404.
6. van der Giessen W.J., Lincoff A.M., Schwartz R.S., van Beusekom H.M., Serruys P.W., Holmes D.R., et al. Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries. Circulation 1996, 94:1690-1697.
7. Schwartz R.S., Holmes D.R., Topol E.J. The restenosis paradigm revisited: an alternative proposal for cellular mechanisms. J Am Coll Cardiol 1992, 20:1284-1293.
8. Bergsma J.E., de Bruijn W.C., Rozema F.R., Bos R.R., Boering G. Late degradation tissue response to poly(l-lactide) bone plates and screws. Biomaterials 1995, 16:25-31.
9. Furie B., Furie B.C. Mechanisms of thrombus formation. N Engl J Med 2008, 359:938-949.
10. Falati S., Gross P., Merrill-Skoloff G., Furie B.C., Furie B. Real-time in vivo imaging of platelets, tissue factor and fibrin during arterial thrombus formation in the mouse. Nat Med 2002, 8:1175-1181.
11. Kim H.I., Takai M., Ishihara K. Bioabsorbable material-containing phosphorylcholine group-rich surfaces for temporary scaffolding of the vessel wall. Tissue Eng Part C Methods 2009, 15:125-133.
12. Ishihara K., Ueda T., Nakabayashi N. Preparation of phospholipid polymers and their properties as polymer hydrogel membrane. Polym J 1990, 22:355-360.
13. Ueda T., Oshida H., Kurita K., Ishihara K., Nakabayashi N. Preparation of 2-methacryloyloxyethyl phosphorylcholine copolymers with alkyl methacrylates and their blood compatibility. Polym J 1992, 24:1259-1269.
14. Ishihara K. Novel polymeric materials for obtaining blood-compatible surfaces. Trends Polym Sci 1997, 5:401-407.
15. Ishihara K. Bioinspired phospholipid polymer biomaterials for making high performance artificial organs. Sci Technol Adv Mater 2000, 1:131-138.
16. Lewis A.L. Phosphorylcholine-based polymers and their use in the prevention of biofouling. Colloids Surf B Biointerfaces 2000, 18:261-275.
17. Ishihara K, Goto Y, Takai M, Matsuno R, Inoue Y, Konno T. Novel polymer biomaterials and interfaces inspired from cell membrane functions. Biochim Biophys Acta, in press, doi:10.1016/j.bbagen.2010.04.008.
18. Sawada S., Iwasaki Y., Nakabayashi N., Ishihara K. Stress response of adherent cells on a polymer blend surface composed of a segmented polyurethane and MPC copolymers. J Biomed Mater Res A 2006, 79:476-484.
19. Ishihara K., Shibata N., Tanaka S., Iwasaki Y., Nakabayashi N., Kurosaki T. Improved blood compatibility of segmented polyurethane by polymeric additives having phospholipid polar group. II. Dispersion state of the polymeric additive and protein adsorption on the surface. J Biomed Mater Res 1996, 32:401-408.
20. Hasegawa T., Iwasaki Y., Ishihara K. Preparation of blood-compatible hollow fibers from a polymer alloy composed of polysulfone and 2-methacryloyloxyethyl phosphorylcholine polymer. J Biomed Mater Res 2002, 63:333-341.
21. Long S.F., Clarke S., Davies M.C., Lewis A.L., Hanlon G.W., Lloyd A.W. Controlled biological response on blends of a phosphorylcholine-based copolymer with poly(butyl methacrylate). Biomaterials 2003, 24:4115-4121.
22. Ishihara K., Nomura H., Mihara T., Kurita K., Iwasaki Y., Nakabayashi N. Why do phospholipid polymers reduce protein adsorption?. J Biomed Mater Res 1998, 39:323-330.
23. Kitano H., Imai M., Mori T., Gemmei-Ide M., Yokoyama Y., Ishihara K. Structure of water in the vicinity of phospholipid analogue copolymers as studied by vibrational spectroscopy. Langmuir 2003, 19:10260-10266.
24. Chen S., Li L., Zhao C., J.Zheng Surface hydration: principles and applications toward low-fouling/nonfouling biomaterials. Polymer 2010, 51:5283-5293.
25. Ishihara K., Oshida H., Endo Y., Ueda T., Watanabe A., Nakabayashi N. Hemocompatibility of human whole blood on polymers with a phospholipid polar group and its mechanism. J Biomed Mater Res 1992, 26:1543-1552.
26. Ishihara K., Ziats N.P., Tierney B.P., Nakabayashi N., Anderson J.M. Protein adsorption from human plasma is reduced on phospholipid polymers. J Biomed Mater Res 1991, 25:1397-1407.
27. Ishihara K., Aragaki R., Ueda T., Watanabe A., Nakabayashi N. Reduced thrombogenicity of polymers having phospholipid polar groups. J Biomed Mater Res 1990, 24:1069-1077.
28. Snyder T.A., Tsukui H., Kihara S., Akimoto T., Litwak K.N., Kameneva M.V., et al. Preclinical biocompatibility assessment of the EVAHEART ventricular assist device: coating comparison and platelet activation. J Biomed Mater Res A 2007, 81:85-92.
29. Yoneyama T., Sugihara K., Ishihara K., Iwasaki Y., Nakabayashi N. The vascular prosthesis without pseudointima prepared by antithrombogenic phospholipid polymer. Biomaterials 2002, 23:1455-1459.
30. Yoneyama T., Ishihara K., Nakabayashi N., Ito M., Mishima Y. Short-term in vivo evaluation of small-diameter vascular prosthesis composed of segmented poly(etherurethane)/2-methacryloyloxyethyl phosphorylcholine polymer blend. J Biomed Mater Res 1998, 43:15-20.
31. Ishihara K., Iwasaki Y., Nakabayashi N. Polymeric lipid nanosphere consisting of water-soluble poly(2-methacryloyloxyethyl phosphorylcholine-co-n-butyl methacrylate). Polym J 1999, 31:1231-1236.
32. Chin-Quee S.L., Hsu S.H., Nguyen-Ehrenreich K.L., Tai J.T., Abraham G.M., Pacetti S.D., et al. Endothelial cell recovery, acute thrombogenicity, and monocyte adhesion and activation on fluorinated copolymer and phosphorylcholine polymer stent coatings. Biomaterials 2010, 31:648-657.
33. Whelan D.M., van der Giessen W.J., Krabbendam S.C., van Vliet E.A., Verdouw P.D., Serruys P.W., et al. Biocompatibility of phosphorylcholine coated stents in normal porcine coronary arteries. Heart 2000, 83:338-345.
34. Pinto Slottow T.L., Waksman R. Overview of the 2007 food and drug administration circulatory system devices panel meeting on the endeavor zotarolimus-eluting coronary stent. Circulation 2008, 117:1603-1608.
35. Kim H.I., Takai M., Konno T., Matsuno R., Ishihara K. Biodegradable polymer films for releasing nanovehicles containing sirolimus. Drug Deliv 2009, 16:183-188.
36. Chuang T.H., Stabler C., Simionescu A., Simionescu D.T. Polyphenol-stabilized tubular elastin scaffolds for tissue engineered vascular grafts. Tissue Eng Part A 2009, 15:2837-2851.
37. Therin M., Christel P., Li S., Garreau H., Vert M. In vivo degradation of massive poly(alpha-hydroxy acids): validation of in vitro findings. Biomaterials 1992, 13:594-600.
38. Sakai O., Nakayama Y., Nemoto Y., Okamoto Y., Watanabe T., Kanda K., et al. Development of sutureless vascular connecting system for easy implantation of small-caliber artificial grafts. J Artif Organs 2005, 8:119-124.
39. Garasic J.M., Edelman E.R., Squire J.C., Seifert P., Williams M.S., Rogers C. Stent and artery geometry determine intimal thickening independent of arterial injury. Circulation 2000, 101:812-818.
40. Sefton M.V., Gemmell C.H., Gorbet M.B. What really is blood compatibility?. J Biomater Sci Polym Ed 2000, 11:1165-1182.
41. Williams D.F. On the mechanisms of biocompatibility. Biomaterials 2008, 29:2941-2953.
42. Boilard E., Nigrovic P.A., Larabee K., Watts G.F., Coblyn J.S., Weinblatt M.E., et al. Platelets amplify inflammation in arthritis via collagen-dependent microparticle production. Science 2010, 327:580-583.
43. Zernecke A., Bernhagen J., Weber C. Macrophage migration inhibitory factor in cardiovascular disease. Circulation 2008, 117:1594-1602.
44. Jiang Y., Beller D.I., Frendl G., Graves D.T. Monocyte chemoattractant protein-1 regulates adhesion molecule expression and cytokine production in human monocytes. J Immunol 1992, 148:2423-2428.
45. Ishii D., Schenk A.D., Baba S., Fairchild R.L. Role of TNF alpha in early chemokine production and leukocyte infiltration into heart allografts. Am J Transplant 2010, 10:59-68.
46. Brodbeck W.G., Patel J., Voskerician G., Christenson E., Shive M.S., Nakayama Y., et al. Biomaterial adherent macrophage apoptosis is increased by hydrophilic and anionic substrates in vivo. Proc Natl Acad Sci U S A 2002, 99:10287-10292.
47. Sawada S., Sakaki S., Iwasaki Y., Nakabayashi N., Ishihara K. Suppression of the inflammatory response from adherent cells on phospholipid polymers. J Biomed Mater Res A 2003, 64:411-416.
48. DeFife K.M., Yun J.K., Azeez A., Stack S., Ishihara K., Nakabayashi N., et al. Adhesion and cytokine production by monocytes on poly(2-methacryloyloxyethyl phosphorylcholine-co-alkyl methacrylate)-coated polymers. J Biomed Mater Res 1995, 29:431-439.
49. Young T.H., Lin D.T., Chen L.Y. Human monocyte adhesion and activation on crystalline polymers with different morphology and wettability in vitro. J Biomed Mater Res 2000, 50:490-498.
50. Diaz-Guerra E., Vernal R., del Prete M.J., Silva A., Garcia-Sanz J.A. CCL2 inhibits the apoptosis program induced by growth factor deprivation, rescuing functional T cells. J Immunol 2007, 179:7352-7357.
51. Collier T.O., Anderson J.M., Brodbeck W.G., Barber T., Healy K.E. Inhibition of macrophage development and foreign body giant cell formation by hydrophilic interpenetrating polymer network. J Biomed Mater Res A 2004, 69:644-650.
52. Granchi D., Ciapetti G., Filippini F., Stea S., Cenni E., Pizzoferrato A., et al. In vitro cytokine production by mononuclear cells exposed to bone cement extracts. Biomaterials 2000, 21:1789-1795.
53. Moro T., Takatori Y., Ishihara K., Konno T., Takigawa Y., Matsushita T., et al. Surface grafting of artificial joints with a biocompatible polymer for preventing periprosthetic osteolysis. Nat Mater 2004, 3:829-836.